Posaconazole Completed Phase 4 Trials for Acute Myeloid Leukemia / Neutropenia / Fungal Infections Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00686543Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)